Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 307

The DOI matches its Crossref record; 725 of the 725 references it cites were found in a registry or an index.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Open access
Lewczuk, Piotr, Riederer, Peter, O’Bryant, Sid E., Verbeek, Marcel M., Dubois, Bruno, Visser, Pieter Jelle, Jellinger, Kurt A., Engelborghs, Sebastiaan, Ramirez, Alfredo, Parnetti, Lucilla, Jack, Clifford R., Teunissen, Charlotte E., Hampel, Harald, Lleó, Alberto, Jessen, Frank, Glodzik, Lidia, de Leon, Mony J., Fagan, Anne M., Molinuevo, José Luis, Jansen, Willemijn J., Winblad, Bengt, Shaw, Leslie M., Andreasson, Ulf, Otto, Markus, Mollenhauer, Brit, Wiltfang, Jens, Turner, Martin R., Zerr, Inga, Handels, Ron, Thompson, Alexander G., Johansson, Gunilla, Ermann, Natalia, Trojanowski, John Q., Karaca, Ilker, Wagner, Holger, Oeckl, Patrick, van Waalwijk van Doorn, Linda, Bjerke, Maria, Kapogiannis, Dimitrios, Kuiperij, H. Bea, Farotti, Lucia, Li, Yi, Gordon, Brian A., Epelbaum, Stéphane, Vos, Stephanie J. B., Klijn, Catharina J. M., Van Nostrand, William E., Minguillon, Carolina, Schmitz, Matthias, Gallo, Carla, Lopez Mato, Andrea, Thibaut, Florence, Lista, Simone, Alcolea, Daniel, Zetterberg, Henrik, Blennow, Kaj, Kornhuber, Johannes, on Behalf of the Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut·2018·The World Journal of Biological Psychiatry

Abstract

In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and update the original paper. New concepts of Alzheimer's disease (AD) and the conceptual interactions between AD and dementia due to AD were developed, resulting in two sets for diagnostic/research criteria. Procedures for pre-analytical sample handling, biobanking, analyses and post-analytical interpretation of the results were intensively studied and optimised. A global quality control project was introduced to evaluate and monitor the inter-centre variability in measurements with the goal of harmonisation of results. Contexts of use and how to approach candidate biomarkers in biological specimens other than cerebrospinal fluid (CSF), e.g. blood, were precisely defined. Important development was achieved in neuroimaging techniques, including studies comparing amyloid-β positron emission tomography results to fluid-based modalities. Similarly, development in research laboratory technologies, such as ultra-sensitive methods, raises our hopes to further improve analytical and diagnostic accuracy of classic and novel candidate biomarkers. Synergistically, advancement in clinical trials of anti-dementia therapies energises and motivates the efforts to find and optimise the most reliable early diagnostic modalities. Finally, the first studies were published addressing the potential of cost-effectiveness of the biomarkers-based diagnosis of neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15622975.2017.1375556

Cites

725 of 725 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 725 references

Cited by

See all 307

Metadata

Authors
Lewczuk, P., Riederer, P., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramirez, A., Parnetti, L., Jack, C. R., Teunissen, C. E., Hampel, H., Lleó, A., Jessen, F., Glodzik, L., de Leon, M. J., Fagan, A. M., Molinuevo, J. L., Jansen, W. J., Winblad, B., Shaw, L. M., Andreasson, U., Otto, M., Mollenhauer, B., Wiltfang, J., Turner, M. R., Zerr, I., Handels, R., Thompson, A. G., Johansson, G., Ermann, N., Trojanowski, J. Q., Karaca, I., Wagner, H., Oeckl, P., van Waalwijk van Doorn, L., Bjerke, M., Kapogiannis, D., Kuiperij, H. B., Farotti, L., Li, Y., Gordon, B. A., Epelbaum, S., Vos, S. J. B., Klijn, C. J. M., Van Nostrand, W. E., Minguillon, C., Schmitz, M., Gallo, C., Lopez Mato, A., Thibaut, F., Lista, S., Alcolea, D., Zetterberg, H., Blennow, K., Kornhuber, J., & on Behalf of the Members of the WFSBP Task Force Working on this Topic: Peter Riederer, C. G.
Venue
The World Journal of Biological Psychiatry
Published
2017-10-27
Volume
19
Issue
4
Pages
244-328
ISSN
  • 1562-2975 (ISSN-L)
  • 1814-1412
OpenAlex
W2765702346
Cited by
307
References
725
FWCI
23.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. https://app.cochat.ai/papers/10.1080/15622975.2017.1375556
The paper
Lewczuk, P., Riederer, P., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramirez, A., Parnetti, L., Jack, C. R., Teunissen, C. E., Hampel, H., Lleó, A., Jessen, F., Glodzik, L., de Leon, M. J., Fagan, A. M., Molinuevo, J. L., . . . on Behalf of the Members of the WFSBP Task Force Working on this Topic: Peter Riederer, C. G. (2018). Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2017.1375556

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.